Safflomin A

Product Details

CAS No:78281-02-4

MF:C27H32O16

Appearance:Orange-yellow powder

Specification:98.5%

UN number:-

Package:1/10/100/500g/bottle

Supply Capacity:KGS

Synonyms:SAFFLOMIN A;Hydroxysafflor yellow A;2,5-Cyclohexadien-1-one, 2,4-di-beta-D-glucopyranosyl-3,4,5-trihydroxy-6-((2E)-3-(4-hydroxyphenyl)-1-oxo-2-propenyl)-;Hydroxysafflor yellow A,SaffloMin A,HSYA;Hydroxysafflor yellow A,Safflomin A;Hydroxysafflor yellow;Safflomin A, 98%, from Carthamus tinctorius L.;HSYA,Hydroxysafflor Yellow A,"Hydroxysafflor Yellow A; Safflomin A; 78281-02-4; HSYA; HI7O919OYZ; (6E)-2,5-dihydroxy-6-[(E)-1-hydroxy-3-(4-hydroxyphenyl)prop-2-enylidene]-2,4-bis[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]cyclohex-4-ene-1,3-dione; 146087-19-6; Hydroxy safflor yellow A; MFCD08435942; UNII-HI7O919OYZ; SCHEMBL21315816; HY-N0567R; CHEBI:139030; GLXC-13517; GLXC-20072; Hydroxysafflor yellow A (Standard); HY-N0567; MSK40276; s9061; AKOS037514823; CCG-270235; CCG-270236; CS-4544; OH08134; 1ST40276; 2,5-Cyclohexadien-1-one, 2,4-di-beta-D-glucopyranosyl-3,4,5-trihydroxy-6-((2E)-3-(4-hydroxyphenyl)-1-oxo-2-propenyl)-; PD087332; 2,4-Di-b-D-glucopyranosyl-3,4,5-trihydroxy-6-[(2E)-3-(4-hydroxyphenyl-1-oxo-2-propen-1-yl)-2,5-cyclohexadien-1-one; 2,4-Di-b-D-glucopyranosyl-3,4,5-trihydroxy-6-[(2E)-3-(4-hydroxyphenyl-1-oxo-2-propen-1-yl)-2,5-cyclohexadien-1-one;Safflomin A; 2,4-di-beta-D-glucopyranosyl-3,4,5-trihydroxy-6-[(2E)-3-(4-hydroxyphenyl-1-oxo-2-propen-1-yl)]-2,5-cyclohexadien-1-one; 2,4-di-beta-D-glucopyranosyl-3,4,5-trihydroxy-6-[(2E)-3-(4-hydroxyphenyl-1-oxo-prop-2-en-1-yl)]cyclohexa-2,5-dien-1-one; 2,5-CYCLOHEXADIEN-1-ONE, 2,4-DI-.BETA.-D-GLUCOPYRANOSYL-3,4,5-TRIHYDROXY-6-((2E)-3-(4-HYDROXYPHENYL)-1-OXO-2-PROPEN-1-YL)-",612.500,C27H32O16,

Product application:Safflomin A, Hydroxysafflor yellow A, HSYA, 78281-02-4, Suzhou Health Chemicals, Safflomin A manufacturer, buy Hydroxysafflor yellow A, Safflomin A price, reference standard Safflomin A, Carthamus tinctorius extract, Safflomin A solubility, anti-thrombotic raw material, Safflomin A 98% HPLC, pharmaceutical grade Safflomin A

 

Safflomin A (Hydroxysafflor Yellow A) exhibits potent pharmacological activities, primarily focused on promoting blood circulation and removing blood stasis. In the pharmaceutical industry, it serves as a key active pharmaceutical ingredient (API) and reference standard for cardiovascular and cerebrovascular drug development, demonstrating significant protective effects against myocardial/cerebral ischemia, thrombosis, and platelet aggregation. Additionally, its outstanding antioxidant and anti-inflammatory properties make it a highly valued functional ingredient in premium nutraceuticals and cosmetic formulations for microcirculation improvement.